English Polski
Tom 16, Nr 3 (2023)
Sprawozdanie z konferencji / Sprawozdanie
Opublikowany online: 2023-09-27

dostęp otwarty

Wyświetlenia strony 310
Wyświetlenia/pobrania artykułu 307
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Wybrane zagadnienia dotyczące terapii komórkowych w świetle doniesień prezentowanych na 33. Regionalnym Kongresie International Society of Blood Transfusion (ISBT) w Göteborgu, 17–21 czerwca 2023 roku

Joanna Janus1, Katarzyna Chmielewska1, Jolanta Antoniewicz-Papis1
Journal of Transfusion Medicine 2023;16(3):160-165.

Streszczenie

Brak

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Schwartz J. Growing variations in cell collections requirements. Vox Sang. 2023; 118(S1). ; 95: PA27–L02.
  2. Thibodeaux S, Aqui N, Park Y, et al. Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies. J Clin Apher. 2022; 37(3): 223–236.
  3. Schafer R. Managing PBMC donors during increasing demand for cell therapeutics. Vox Sang. 2023; 118(S1). ; 95: PA27–L01.
  4. Maurer K, Kim HT, Garrity HM, et al. Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells. Blood Adv. 2023; 7(11): 2431–2435.
  5. Maurer K, Kim HT, Kuczmarski TM, et al. Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution. Blood Adv. 2021; 5(23): 5140–5149.
  6. Moazzeni A, Kheirandish M, Khamisipour G, et al. Leukoreduction filters (LRFs) as a novel source of CAR-NK cell based immunotherapy. Vox Sang. 2023; 118(S1). ; 46: PA09–L02.
  7. Perez-Lopez S, Alvarez-Viejo M, Perez-Basterrechea M, et al. Pressure ulcer treatment with autologous bone-marrow mononuclear stem cells. EudraCT 2008-003015-12 results. Vox Sang. 2023; 118(S1). ; 110: A32–L03.
  8. Khan A, Rodriguez-Romera A, Reyat J, et al. Bone Marrow Organoids. Vox Sang. 2023; 118(S1). ; 47: PA09–L04.
  9. Rangel M, Pinho C, Bordalo F, et al. Real World Evidence (RWE) to assess effectiveness andsafety of donors during and after cell and bone marrow collection. Vox Sang. 2023; 118(S1). ; 368: P532.
  10. Kim N, Park S, Kwon S, et al. Unrelated hematopoietic stem cell donor recruitment of the Korean Red Cross Blood Services (2019-2022): The effect of repeat blood donor targeted recruitment. Vox Sang. 2023; 118(S1). ; 365: P526.
  11. Useini S, et al. Grubovic Rastvorceva R, . Stojanoski Z. Overview of apheresis collection of peripheral blood stem cells in hematologic patients and healthy donors. Vox Sang. 2023; 118(S1). ; 365: 528.
  12. Jacobsen B, Teigum I, Gravås M. Validation of cryopreservation method for autologous hematopoietic stem cells without hydroxyethyl starch. Vox Sang. 2023; 118(S1). ; 366: P529.
  13. Al-Mozain N, Al-Alem S, Al-Madhi S. Reducing the DMSO concentration in the cryopreservation mixture from 10% to 5% improves cell viability, results of a validation study. Vox Sang. 2023; 118(S1). ; 369: P537.
  14. Larrea L, Vaya M, Vera B. An alternative washing solution for the thawing of cryopreserved hematopoietic stem cells. Vox Sang. 2023; 118(S1). ; 367: P530.